CONTROVERSY IN TREATING THE OLDEST OLD WITH HYPERTENSION: IS THE HYPERTENSION IN THE VERY ELDERLY TRIAL THE FINAL ANSWER?
β Scribed by Dmitry Abramov; Huai Cheng
- Book ID
- 109130471
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 46 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0002-8614
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Fortyβtwo elderly patients (mean age, 66.2 Β± 5.1 yr) with hypertension, treated for an average of 17.3 years (standard deviation, 10.3), and 42 control subjects (mean age, 66.5 Β± 4.8yr), matched for age, sex, and level of education, were studied with regard to the detection of lesions i
A newly developed calcium antagonist, nilvadipine, was administered to 7 hypertensive patients aged 75.6 y. Nilvadipine 4 mg b.d. decreased the average 24-h blood pressure significantly from 169/89 mmHg to 152/81 mmHg after 7 to 14 days without any change in the pulse rate. The circadian patterns of
Increased oxidative stress is a well-known phenomenon in dialysis patients. However, the contribution of hypertension to the oxidative stress in peritoneal dialysis patients has not yet been assessed. The present study aimed to investigate if hypertension had an additional effect on oxidative stress